A report in The Daily Beast quotes prominent vaccine skeptic Dr. Aseem Malhotra—an advisor to Health and Human Services Secretary Robert F. Kennedy Jr.—saying the Trump administration plans to withdraw COVID-19 vaccines from the U.S. market “within months.” According to Malhotra, Kennedy and “influential members of President Trump’s family” are aligned in the view that these vaccines should no longer be prescribed pending further research.
In May 2025, the FDA introduced a new framework that limits COVID-19 vaccine approval to adults 65 and older, or younger individuals with underlying health conditions. As a result, healthy children and adults under 65 now require more rigorous data for approval, and the agency no longer endorses routine annual boosters for low-risk populations.
The CDC also replaced its advisory committee in June with members known to hold skeptical views toward mRNA vaccines. Simultaneously, HHS Secretary Kennedy canceled nearly $500 million in federal funding for mRNA vaccine research, stalling potential development of new vaccines.
While public health professionals and institutions have vehemently opposed mRNA vaccine skepticism, “expert” consensus in 2020 and 2021 was based on limited evidence and rapidly changing science. Predictions about lasting immunity, overwhelming deaths among healthy young people, and similar doomsday scenarios did not pan out. That history complicates the tendency to treat expert opinion as infallible.
For current policy discussions—especially those that are highly controversial—skepticism about expert consensus stems not only from ideological disagreement but also from legitimate reflection on past errors.
In another significant shift, the CDC’s new COVID-19 immunization workgroup is now led by Retsef Levi, a known mRNA vaccine skeptic who has previously called for their outright removal. His leadership signals a clear departure from earlier CDC policy.
Despite the ominous language from Malhotra, the White House has called these reports speculative. Spokesperson Kush Desai stated, “The Administration is relying on Gold Standard Science… Unless announced by the Administration, however, any discussion about HHS policy should be dismissed as baseless speculation.”
The idea of fully pulling COVID-19 vaccines—especially from public distribution—would mark a sharp departure from previous global policy. If such a decision is made, it would likely provoke legal challenges, intense public debate, and potential actions at the state or local level, where several jurisdictions are already considering diverging policies on vaccine availability.
READ NEXT: Trump Administration Orders Federal Agencies To Scrub Employees’ COVID Vaccine Records
Shelve any COVID vaccines. Use tested successful drugs, eg. Interferon, etc.